The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder

BACKGROUND: The high risk of recurrence faced by patients with bladder cancer has necessitated the administration of supplemental intravesical chemotherapy; however, such treatments often result in severe side effects. As a result, novel intravesical agents with enhanced efficacy and minimal toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chi-Chen, Lin, Mei-Yi, Chen, Syue-Yi, Shen, Cheng-Huang, Chen, Lih-Geeng, Hsieh, Hsiao-Yen, Chan, Michael WY, Hsu, Cheng-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599278/
https://www.ncbi.nlm.nih.gov/pubmed/23433042
http://dx.doi.org/10.1186/1472-6882-13-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599278/
https://www.ncbi.nlm.nih.gov/pubmed/23433042
http://dx.doi.org/10.1186/1472-6882-13-44

Ejemplares similares